Lumbar CSF 5-hydroxyindoleacetic acid and homovanillic acid in affective syndromes.
D000328:Adult; D000342:Affective Symptoms / Q000134:cerebrospinal fluid*; D000639:Amitriptyline / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D001714:Bipolar Disorder / Q000134:cerebrospinal fluid / Q000188:drug therapy; D001923:Brain Chemistry / Q000187:drug effects; D002415:Cats; D003863:Depression / Q000134:cerebrospinal fluid / Q000188:drug therapy; D005260:Female; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid*; D008094:Lithium / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010624:Phenelzine / Q000494:pharmacology / Q000627:therapeutic use; D010648:Phenylacetates / Q000134:cerebrospinal fluid*; D011339:Probenecid; D051381:Rats; D012890:Sleep / Q000187:drug effects; D013129:Spinal Puncture
D010648:Phenylacetates; D000639:Amitriptyline; D006897:Hydroxyindoleacetic Acid; D008094:Lithium; D010624:Phenelzine; D011339:Probenecid; D006719:Homovanillic Acid